These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4792935)

  • 21. Dietary clofibrate inhibits induction of hepatic antioxidant enzymes by chronic estradiol in female ACI rats.
    Mesia-Vela S; Sanchez RI; Reuhl KR; Conney AH; Kauffman FC
    Toxicology; 2004 Aug; 200(2-3):103-11. PubMed ID: 15212807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the hepatic microbody membrane in freeze-fracture replicas.
    Reddy JK; Tewari JP; Svoboda DJ; Malhotra SK
    Lab Invest; 1974 Sep; 31(3):268-75. PubMed ID: 4413769
    [No Abstract]   [Full Text] [Related]  

  • 23. Inhibition of the biosynthesis of sterols by phenyl and phenolic compounds in rat liver.
    Ranganathan S; Ramasarma T
    Biochem J; 1973 Jul; 134(3):737-43. PubMed ID: 4749274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol metabolism in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate).
    Kähönen MT; Ylikahri RH; Hassinen I
    Life Sci II; 1971 Jun; 10(12):661-70. PubMed ID: 5560535
    [No Abstract]   [Full Text] [Related]  

  • 25. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
    White LW
    J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
    [No Abstract]   [Full Text] [Related]  

  • 26. Polydispersity of rat liver peroxisomes induced by the hypolipidemic and carcinogenic agent clofibrate.
    Flatmark T; Christiansen EN; Kryvi H
    Eur J Cell Biol; 1981 Apr; 24(1):62-9. PubMed ID: 7238535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microbodies in experimentally altered cells. 8. Continuities between microbodies and their possible biologic significance.
    Reddy J; Svoboda D
    Lab Invest; 1971 Jan; 24(1):74-81. PubMed ID: 4322703
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of clofibrate on the enzyme activity of the rat small intestine epithelium].
    Antonenkov VD
    Biokhimiia; 1983 May; 48(5):763-7. PubMed ID: 6871286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proliferation of microbodies and synthesis of catalase in rat liver. Induction in tumor-bearing host by CPIB.
    Reddy J; Svoboda D
    Am J Pathol; 1971 Apr; 63(1):99-108. PubMed ID: 4323477
    [No Abstract]   [Full Text] [Related]  

  • 30. [Derivatives of para-chlorphenoxyisobutyric acid as hypocholesteremic agents].
    Klebanov BM
    Farmakol Toksikol; 1970; 33(3):324-7. PubMed ID: 5453029
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhancement of choline dehydrogenase activity in rat liver mitochondria by clofibrate feeding.
    Kramar R; Kremser K; Raab R
    Hoppe Seylers Z Physiol Chem; 1984 Oct; 365(10):1207-10. PubMed ID: 6394466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of clofibrate on serum and hepatic lipids in nephrotic rats.
    Hoak JC; Connor WE; Armstrong ML; Warner ED
    Lab Invest; 1968 Oct; 19(4):370-5. PubMed ID: 5699117
    [No Abstract]   [Full Text] [Related]  

  • 33. The in vitro effect of clofibrate on platelet aggregation.
    Davis JW; Wilson SJ; McField JR
    Am J Med Sci; 1966 Dec; 252(6):697-700. PubMed ID: 5954672
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of clofibrate treatment on the activity of carnitine acetyltransferase in rat tissues.
    Kähönen MT; Ylikahri RH
    FEBS Lett; 1974 Aug; 43(3):297-9. PubMed ID: 4413032
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of clofibrate on intracellular enzyme distribution in the rat liver].
    Panchenko LF; Popova SV; Pirozhkov SV; Antonenkov VD
    Tsitologiia; 1983 Nov; 25(11):1302-8. PubMed ID: 6659071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of liver and kidney catalase to alpha-p-chlorophenoxyisobutyrate (clofibrate) in C57B1/6J male mice of different ages.
    Baird MB; Zimmerman JA; Massie HR; Samis HV
    Gerontologia; 1974; 20(3):169-78. PubMed ID: 4461328
    [No Abstract]   [Full Text] [Related]  

  • 37. Clofibrate-induced changes in the activity of human intestinal enzymes.
    Zakim D; Herman RH; Rosensweig NS; Stifel FB
    Gastroenterology; 1969 Mar; 56(3):496-9. PubMed ID: 5766905
    [No Abstract]   [Full Text] [Related]  

  • 38. Hepatic microsomal enzyme induction, beta-oxidation, and cell proliferation following administration of clofibrate, gemfibrozil, or bezafibrate in the CD rat.
    Amacher DE; Beck R; Schomaker SJ; Kenny CV
    Toxicol Appl Pharmacol; 1997 Jan; 142(1):143-50. PubMed ID: 9007043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modes and levels of action of clofibrate].
    Thorp JM
    Rev Atheroscler (Paris); 1966; 8(1):2-11. PubMed ID: 5960552
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum phospholipid alterations and their control by chlorophenoxyisobutyrate and betabenzalbutyrate in puromycin aminonucleoside induced nephrotic syndrome in the rat.
    Gallt C; Edwards KD; Paoletti R
    Life Sci II; 1970 May; 9(9):523-34. PubMed ID: 5452796
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.